Live from the NIH registry
Studies recruiting near Harrisburg right now
Top 25 of 399 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
WellSpan Health — York, Pennsylvania (23.1 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Penn State Health — Hershey, Pennsylvania (12.4 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (23.1 mi)
· Sponsor: AbbVie
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
Rib Fracture Multiple
N/A
Interventional 60 participants sought
Wellspan Health York Hospital — York, Pennsylvania (23.1 mi)
· Sponsor: WellSpan Health
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Giselle Sholler
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer, c-MET
Phase 2
Interventional 150 participants sought
Cancer Care Associates Of York /ID# 270971 — York, Pennsylvania (23.1 mi)
· Sponsor: AbbVie
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Heart and Vascular Research at WellSpan Health — York, Pennsylvania (23.1 mi)
· Sponsor: Eli Lilly and Company
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Cancer Care Associates of York (site 206) — York, Pennsylvania (23.1 mi)
· Sponsor: VM Oncology, LLC
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2
Interventional 249 participants sought
Cancer Care Associates Of York — York, Pennsylvania (23.1 mi)
· Sponsor: Loxo Oncology, Inc.
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Wellspan York Hospital — York, Pennsylvania (23.1 mi)
· Sponsor: Shockwave Medical, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Susquehanna Research Group — Harrisburg, Pennsylvania (0.1 mi)
· Sponsor: Janssen Research & Development, LLC
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Camp Hill, Pennsylvania (3.1 mi)
· Sponsor: Enveda Therapeutics
Reduction of Adverse Drug Events and Readmissions
Pharmacogenomic Testing for Medication Management
N/A
Observational 280,000 participants sought
MD@Home — York, Pennsylvania (23.1 mi)
· Sponsor: ClinLogic LLC
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (0.1 mi)
· Sponsor: SWOG Cancer Research Network
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Steba Biotech S.A.
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Canadian Cancer Trials Group
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Osteosarcoma, Ewing Sarcoma
Phase 2
Interventional 406 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Milton S. Hershey Medical Center
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
Cholecystitis, Acute, Biliary Diseases
N/A
Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (23.1 mi)
· Sponsor: WellSpan Health
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
WellSpan Health-York Cancer Center — York, Pennsylvania (23.1 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Penn State Hershey — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Novartis Pharmaceuticals
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Cancer Care Associates of York — York, Pennsylvania (23.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
NSCLC, Stage I
Phase 2
Interventional 244 participants sought
Penn State Cancer Institute — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Greg Durm, MD
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Endometrial Cancer
N/A
Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (23.1 mi)
· Sponsor: WellSpan Health
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced
N/A
Interventional 900 participants sought
Penn State University / Penn State Children's Hospital — Hershey, Pennsylvania (12.4 mi)
· Sponsor: University of Michigan
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania (12.4 mi)
· Sponsor: Regeneron Pharmaceuticals